loadpatents
name:-0.015655040740967
name:-0.016944885253906
name:-0.0048189163208008
CLOAD; Sharon Patent Filings

CLOAD; Sharon

Patent Applications and Registrations

Patent applications and USPTO patent grants for CLOAD; Sharon.The latest application filed is for "fibronectin based scaffold domain proteins that bind to myostatin".

Company Profile
3.9.12
  • CLOAD; Sharon - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20190307855 - CLOAD; Sharon ;   et al.
2019-10-10
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 10,406,212 - Cload , et al. Sept
2019-09-10
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 10,245,302 - Cload , et al.
2019-04-02
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20170354718 - CLOAD; Sharon ;   et al.
2017-12-14
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 9,662,373 - Cload , et al. May 30, 2
2017-05-30
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20170088602 - CLOAD; Sharon ;   et al.
2017-03-30
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 9,493,546 - Cload , et al. November 15, 2
2016-11-15
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20150231211 - CLOAD; Sharon ;   et al.
2015-08-20
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 8,993,265 - Cload , et al. March 31, 2
2015-03-31
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20150072919 - CLOAD; Sharon ;   et al.
2015-03-12
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 8,933,199 - Cload , et al. January 13, 2
2015-01-13
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20140309163 - CLOAD; Sharon ;   et al.
2014-10-16
Fibronectin based scaffold domain proteins that bind to myostatin
Grant 8,853,154 - Cload , et al. October 7, 2
2014-10-07
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20140107020 - CLOAD; Sharon ;   et al.
2014-04-17
Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin
App 20140105896 - CLOAD; Sharon ;   et al.
2014-04-17
Materials and methods for the generation of transcripts comprising modified nucleotides
Grant 8,101,385 - Cload , et al. January 24, 2
2012-01-24
Materials and methods for the generation of transcripts comprising modified nucleotides
App 20100120024 - Cload; Sharon ;   et al.
2010-05-13
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
Grant 7,579,450 - Burmeister , et al. August 25, 2
2009-08-25
Metabolic profile directed aptamer medicinal chemistry
App 20090075342 - Cload; Sharon ;   et al.
2009-03-19
Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics
App 20090018093 - Cload; Sharon ;   et al.
2009-01-15
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
App 20070009907 - Burmeister; Paula ;   et al.
2007-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed